Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Identifying Outsourcing Trends in Pharmaceutical and Biotechnology Contract Manufacturing - Frost & Sullivan is launching a new end user study on outsourcing trends, perceptions, selection criteria, and other important dynamics to contract manufacturing organizations (CMOs)
Identifying Outsourcing Trends in Pharmaceutical and Biotechnology Contract Manufacturing

 

PRZOOM - /newswire/ - Palo Alto, CA, United States, 2008/03/12 - Frost & Sullivan is launching a new end user study on outsourcing trends, perceptions, selection criteria, and other important dynamics to contract manufacturing organizations (CMOs).

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The study includes detailed interviews with more than 150 executives within the pharmaceutical and biotechnology industry involved in outsourcing to CMOs, with the objective of elucidating opportunities and threats and providing a greater understanding for parties interested in competing in this market.

If you are interested in sponsoring, shaping or participating in the research for this study - Contract Manufacturing Organizations: What Pharmaceutical and Biotechnology Companies Want and How to Compete for their Business, then send an email to Melina Trevino - Corporate Communications at melina.trevino[.]frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. Upon receipt, we will then forward this information to our research team who will contact you at the above information.

"Understanding how outsourcers make decisions and evaluate providers is vital to services companies," notes Frost & Sullivan Industry Manager, Daniel Ruppar. "Analyzing feedback on these dynamics provides CMOs a sound basis for formulating an effective strategy to compete in the U.S. market."

The rapid growth of contract manufacturing presents both challenges and opportunities. Within the biotechnology market, there are concerns about capacity constraints as biopharma interest continues to expand. The potential for growth is huge in emerging markets where there is already a significant amount of primary contract manufacturing of active pharmaceutical ingredients (APIs). Specialty pharmaceutical companies, which have not invested much in building manufacturing capacity, are also driving the demand for CMO services.

This study will survey CMO customers to better understand their preferences and current and future outsourcing patterns. Other key objectives of the survey include: the ability to understand the decision making dynamics within organizations, identifying key parties involved in outsourcing initiation, recommendation, approval and CMO performance evaluation and understanding what services and business models are appealing to outsourcers in the industry. Both pharmaceutical and biotechnology contract manufacturing will be assessed in the scope of this research, with a focus on final dosage form manufacturing.

"Manufacturers that can better understand the service models and business attributes that appeal to pharmaceutical and biotechnology companies, can develop and refine their operations to best serve customer demand," says Ruppar. "With effective information partners, companies can take important steps to ensure and accelerate their future growth."

Contract Manufacturing Organizations: What Pharmaceutical and Biotechnology Companies Want and How to Compete for their Business is part of ongoing research conducted within the Pharmaceutical and Biotechnology market, which also includes research in the following areas: Contract Research and Manufacturing, Specialty Pharmaceuticals, Biopharmaceuticals, Vaccines, and Drug Delivery. Recent titles include: Global Biopharmaceutical Contract Manufacturing Markets, Global CRO Spending Trends, and U.S. Specialty Pharmaceuticals – Overview and Trends. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Analyst Interviews are available to the press.

Frost & Sullivan, the Global Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Identifying Outsourcing Trends in Pharmaceutical and Biotechnology Contract Manufacturing

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Melina Trevino 
210.247.2440 melina.trevino[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  Intrinsic Executive Search Ltd

Visit  MagLar, Inc.







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today